Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 1, 2016
Pharmacy Choice - News - U.S. FDA Final Approvals (Drugs & Devices) - July 1, 2016

Pharmacy News

 U.S. FDA Final Approvals (Drugs & Devices)
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
<< Back     Articles(s): 26 - 30 of 30     Go To Page:

6/25/16 - FDA Okays Trial for Medtronic's MRI-Guided Epilepsy Device [Daily Tribune (Bahrain)]
Medtronic plc MDT recently won the FDA's Investigational Device Exemption for the SLATE trial, which will evaluate this medical technology giant's Visualase MRI-Guided Laser Ablation technology. The SLATE study aims at enrolling 120 adult patients suffering from drug-resistant MTLE, who will be treated at selected epilepsy centers across the U.S. P
6/25/16 - T3D Therapeutics Receives FDA Approval for a 6-Month, Open-Label Extension to its Phase 2a Trial of T3D-959 for Treatment of Mild to Moderate... [Seven Days (United Arab Emirates)]
-T3D Therapeutics, Inc., a clinical stage drug development company targeting Alzheimers disease, is announcing that the U.S. Food and Drug Administration has granted approval for a 26- week, open-label extension to its 2- week Phase 2 a clinical trial of T3D-959 in a limited number of subjects who completed the main Phase 2 a study for the treatmen
6/24/16 - Endocure Technologies, Inc., A Wholly Owned Subsidiary Of MedServ Technologies, Inc., Has Received FDA 510k Clearance For The Manufacture Of Its New...
Endocure Technologies, Inc., A Wholly Owned Subsidiary Of MedServ Technologies, Inc., Has Received FDA 510 k Clearance For The Manufacture Of Its New Endocure Model EUR078A Urology Endoscope. By a News Reporter-Staff News Editor at Health& Medicine Week Endocure Technologies, Inc., our medical R&D and OEM company, has received FDA 510 clearance f
6/24/16 - Natco Pharma ends 4% higher; gets FDA nod for Glycopyrrolate Tablets [India Infoline News Service]
Natoco Pharma ended 3.8% higher after the company clarified to the BSE regarding USFDA approval the company received for generic version of Glycopyrrolate Tablets. "We received from our US agent on 22nd June 2016 intimating the approval for generic version of Glycopyrrolate Tablets 1 mg and 2 mg from US FDA. We have not disclosed the said news to a
6/24/16 - Unichem Lab closes 2% lower despite FDA nod for Alzheimer's drug [India Infoline News Service]
Shares of Unichem Laboratories ended 2.15% lower at Rs.266.25 on BSE despite the company announced that it has received ANDA approval from the United States Food and Drug Administration for Donepezil Hydrochloride Tablets USP. Donepezil Hydrochloride Tablets USP 5 mg and 10 mg are therapeutically equivalent to Aricept Tablets, 5 mg and 10 mg of Eis
<< Back     Articles(s): 26 - 30 of 30     Go To Page:


© 2016 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415